Skip to main content

Table 1 Synopsis of clinical, radiologic, laboratory and therapeutic characteristics in 8 patients with BCS

From: Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts

Case

Age at onset

(years)

Sex

Symptoms at BCS onset

BCS-type lesion size

(cm) at onset

Pattern of BCS-type lesion Gd+

Coexistence of brain

MS-like plaques

Barkof criteria

fulfillment at BCS onset

Spinal cord lesions at BCS onset

CSF

OCBs

Time to follow-up from BCS onset

(months)

Response to IVMP

Long-term Treatment

1

24

M

right-sided hemiparesis and hemianaesthesia

2.8

Peripheral Gd + at outer layer

(+)

No

(−)

(+)

85

poor

CYC

2

30

F

dysarthria,left facial palsy, left hand dexterity problems

3.6

Peripheral ring-like Gd + at outer layer

(−)

No

(−)

(+)

34

poor

CYC

3

41

M

Wernicke’s aphasia and right-sided hemianaesthesia

2.6

Peripheral ring-like Gd + at outer two layers

(+)

No

(−)

Not tested

132

poor

1st MTX

2nd GA

4

18

F

blurred vision

3.1

Peripheral incomplete ring-like Gd + at outer two layers

(+)

Yes

(−)

(+)

16

excellent

1st GA,

2nd NTZ

5

18

F

right-sided hemiparesis

2

Peripheral ringlike Gd + at outer layer

(+)

Yes

(+)

Not tested

127

good

1st IFN-beta-1b,

2nd NTZ

6

26

M

dysarthria

3.6

Peripheral incomplete ringlike Gd + at outer two layers

(+)

Yes

(−)

(−)

23

poor

RTX

7

26

F

gait instability, mild left hemiparesis

1.7

peripheral Gd + at outer layer

(+)

No

(+)

(+)

29

poor

RTX

8

27

M

left facial nerve palsy

1.8

partial ringlike Gd+

(+)

No

(−)

(−)

9

poor

CYC

  1. Abbreviations: BCS Baló’s Concentric Sclerosis, F Female, M: Male, Gd+ Gadolinium Enhancement, CSF OCBs Cerebrospinal Fluid Oligoclonal Bands, (+) presence, (−) absence, MS Multiple Sclerosis, IVMP intravenous methylprednisolone, CYC Cyclophosphamide, MTX Mitoxantrone, RTX Rituximab, GA Glatiramer acetate